{"id":"fludarabine-plus-darbopoetin","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Anemia"},{"rate":null,"effect":"Thrombocytopenia"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fludarabine is a purine analog that acts as a nucleotide antimetabolite, inhibiting ribonucleotide reductase and DNA polymerase to induce apoptosis in lymphoid malignancies. Darbopoetin alfa is an erythropoiesis-stimulating agent that binds to the erythropoietin receptor to increase hemoglobin levels and reduce transfusion requirements in patients experiencing chemotherapy-related anemia.","oneSentence":"Fludarabine inhibits DNA synthesis in leukemic cells while darbopoetin stimulates red blood cell production to counteract chemotherapy-induced anemia.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:46:51.030Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic lymphocytic leukemia (CLL)"}]},"trialDetails":[{"nctId":"NCT00281892","phase":"PHASE3","title":"Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia","status":"COMPLETED","sponsor":"German CLL Study Group","startDate":"2004-09","conditions":"Chronic Lymphocytic Leukemia, Anemia","enrollment":97}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Fludarabine plus Darbopoetin","genericName":"Fludarabine plus Darbopoetin","companyName":"German CLL Study Group","companyId":"german-cll-study-group","modality":"Biologic","firstApprovalDate":"","aiSummary":"Fludarabine plus Darbopoetin is being studied as a treatment for Chronic Lymphocytic Leukemia and Anemia in older patients. This combination is being investigated in a clinical trial led by the German CLL Study Group.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}